Salta al menu principale di navigazione Salta al contenuto principale Salta al piè di pagina del sito

Saggi, Studi e Ricerche

N. 57 (2022)

Infection diseases in the prisons: A public health warming. Priority action to protect general community

19 luglio 2022


The infectious diseases are the most prevalent illnesses in prisoners, and they have a relevant burden for the society. Several studies have shown that the screening and the treatment of the infectious diseases inside prisons may be effective in reducing their burden in the general community.
The main aim of the study was to determine between 2019-2021 the incidence and the prevalence of HIV, HBV, HCV, TB and syphilis in the people inside Padua prisons.
The study has demonstrated that the screening of the infectious diseases in detainees was very high, raising in 2021 in the entrant people the 100%. The research also has shown that during 2021 the most prevalent incidence of infectious diseases was for TB (16.3%), followed by HCV (11.3%), HBV (7.9%) and HIV (1.6%). Interestingly, our data has indicated how during 2021 versus the previous years the prevalence of the infectious diseases increased for HBV (41.5%), HCV (18.8%), and TB (48.1%). These data indicate as different conditions such as the geographic origin of the prisoners people or several environmental factors such as the overcrowding may influence the prevalence of the infectious disease inside prisons.
The study suggests how the prisons may represent a place where may be easier the treatment of the patients affected by infectious diseases and how universal and periodic screening campaigns and facilitated treatment programs as the point of care may increase the access to care and to control the spread of infectious also in the general community.

Riferimenti bibliografici

  1. Aldridge R.W., Story A., Hwang S.W., Nordentoft M., Luchenski S.A., Hartwell G., Tweed E.J., Lewer D., Katikireddi S.V., Hayward A.C. (2017). Morbidity and mortality in homeless individuals, prisoners, sex workers, and individuals with substance use disorders in high income countries: a systematic review and meta-analysis. Lancet, 391: 241-250.
  2. Altice F.L., Mostashari F., Selwyn P.A. et al. (1998). Predictors of HIV infection among newly sentenced male prisoners. J. Aquir. Immune Defic. Syndr. Hum. Retrovirol., 18(5): 444-453.
  3. Altice F.L., Marinovich A., Khoshnood K. et al. (2005). Correlates of HIV infection among incarcerated women: implications fro improving
  4. detection of HIOV infection. J. Urban Health, 82(2): 312-326.
  5. Altice F.L., Azbel L., Stone J. et al. (2016). The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia. Lancet, 388(10050): 1228-1248.
  6. Alvarado Esquivel C., Sablon E., Martinez-Garcia S., Estrada-Martinez S. (2005). Hepatitis virus and HIV infections in inmates of a state
  7. correctional facility in Mexico. Epidemiol. Infect., 133(4): 679-685.
  8. Andrinopoulos K., Kerrigan D., Figueroa J. et al. (2010). Establishment of an HIV/sexually transmitted disease programme and prevalence of infection among incarcerated men in Jamaica. Int. J. STD AIDS, 21(2): 114-119.
  9. Andrus J.K., fleming D.W., Knox C. et al. (1989). HIV testing in prisoners: is mandatory testing mandatory? Am. J. Public Health., 79(7): 840-842.
  10. Azbel L., Polonsky M., Wegman M. et al. (2016). Intersecting epidemics of HIV, HCV, and syphilis among soon-to-be released prisoners in Kyrgyzstan: implications for prevention and treatment. Int. J. Drug Policy, 37: 9-20.
  11. Bick J.A. (2007). Infection control in jails and prisons. Clin. Infect. Dis., 45(8): 1047-1055.
  12. Binswanger I.A., Blatchford P.J., Forsyth S.J., Stern M.F., Kinner S.A. (2016). Epidemiology of infectious disease-related death after release from prison, Washington Stare, United States, and Queensland, Australia: a cohort study. Public Health Rep., 131(4): 574-582.
  13. Bosworth R., Borschmann R., Altice F.L., Kinner S.A., Dolan K., Farrell M. (2022). HIV/AIDS, hepatitis and tuberculosis-related mortality among incarcerated people: a global scoping review. Int. J. Prison Health, 18(1): 66-82.
  14. Clarke J.G., Waring M.E. (2012). Overweight, obesity, and weight change among incarcerated women. J. Correct Health Care, 18(4): 285-292.
  15. Cropsey K.L., Wexler H.K., Melnick G. et al. (2007). Specialized prisons and services: results from a national survey. Prison J., 87: 58-85.
  16. Deiss R.G., Rodwell T.C., Garfein R.S. (2009). Tubercolosis and illicit drug use: review and update. Clin. Infect., 48(1): 72-82.
  17. Degenhardt L., Whiteford H.A., Ferrari A.J. et al. (2013). Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2019. Lancet, 382(9904): 1564-1574.
  18. Dolan K., Wirtz A.l., Moazeb B. et al. (2016). Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees. Lancet,
  19. (10049): 1089-1102.
  20. Hanass-Hancok J., Chappel P., Myezwa H. et al. (2016). Committing to disability inclusion to end AIDS by 2030. Lacent HIV, 3(12): e556-e557.
  21. Houle B. (2014). The effect of incarceration on adult male BMI trajectories, USA, 1981-2006. J. Racial Ethn Health Disparities, 1(1): 21-28.
  22. Howel B.A., Long J.B., Edelman E.J. et al. (2016). Incarceration history and uncontrolled blood pressure in a multisite cohort. J. Gen. Intern. Med., 31(12): 1496-1502.
  23. Kamarulzaman A., Reid S.E., Scwitters A. et al. (2016). Prevention of transmission of HIVm hepatitis B virus, hepatitis C virus, and tuberculosis in prisoners. Lancet, 388 (10049): 1115-1126.
  24. Massoglia M. (2008). Incarceration as exposire: the prison, infectious disease, and other stress-related illnesses. J. Health Soc. Behav., 49(1): 56-71.
  25. Massoglia M., Menster B. (2019). Linkages between incarceration and health. Public health reports, 134(Suppl. I): 8S-14S.
  26. Massoglia M., Pridemore W.A. (2015). Incarceration and health. Annu. Rev. Sociol., 41: 291-310.
  27. Massoglia M., Pare P.P., Schnittker J., Gagnon A. (2014). The relationship between incarceration and premature adult mortality: gender specific evidence. Soc. Sci. Res., 46: 142-154.
  28. Nava F.A., Bassetti G., Cristofoletti M., Fornaini M., Geraci R., Paties M., Poggi C., Tolio S., Pilerci C. (2021). Hepatitis delta is a public health concern in the community setting: The role of prison health care units in limiting the spread of infection in general population. Mission – Italian Quarterly Journal of Addiction, 56: 43.
  29. Ndeffo-Mbah M.L., Vigliotti V.S., Skrip L.A., Dolan K., Galvani A.P. (2018). Dynamic models of infectious disease transmission in prisons and the general population. Epidemiol. Rev., 40: 40-57.
  30. Niveau G. (2006). Prevention and infectious disease transmission in correctional settings: a review. Public Health, 120(1): 33-41.
  31. Rich J.D., Beckwith C.G., Macmadu A. et al. (2016). Clinical care of incarcerated people with HIV, viral hepatitis, or tuberculosis. Lancet, 388(10049): 1103-1114.
  32. Roberts J.M., Redman C.W. (1993). Pre-eclampsia: more than pregnancyindiced hypertension. Lancet, 341(8858): 1447-1451.
  33. Rosen D.L., Wohl D.A., Schoenbach V.J. (2011). All-cause and cause-specific mortality among black and white North Carolina state prisoners, 1995-2005. Ann. Epidemiol., 21(10): 719-726.
  34. Sayyah M., Rahim F., Kayedani G.A., Shirbandi K., Saki Malehi A. (2018). Global view of HIV prevalence in prisons: a systematic review and metaanalysis. Iran J. Public Health, 48: 217-226.
  35. Schnittker J., John A. (2007). Enduring stigma: the long-term effects of incarceration on health. J. Health Soc. Behav., 48(2): 115-130.
  36. Seval N., Wucel A., Gunderson C., Grimshaw A., MSLIS, Springer S.A. (2020). The impact of medication for opioid use disorder on hepatitis C incidence among incarcerated persons: a systematic review. Infect. Dis. Clin. North Am., 34(3): 559-584.
  37. Spaulding A.C., Seals R.M., McCallum V.A., Perez S.D., Brzozowski A.K., Steenland N.K. (2011). Prisoner survival inside and outside of the
  38. institution: implications for health-care planning. Am. J. Epidemiol., 173(5): 479-487.
  39. Stone J., Fraser H., Lim A.G., Walker J.G., Ward Z., MacGregor L., Trickey A., Abbott S., Strathdee A.A., Abromovitz D., Maher L., Iversen J., Bruneaus J., Zang G., Garfein R.S., Yen Y.F., Azim T., Mehta S.H., Millay M.J., Hellard M.E., Scks-Davis R., Dietze P.M., Aitken C., Aladashvili M., Tsertvadze T., Mravck V., Alary M., Roy E., Smyrnov P., Sazonova Y., Young A.M., Havens J.R., Hope V.D., desai M., Heinsbroek E., Hutchinson S.J., Palmateer N.E., McAuley A., Platt L., Martin N.K., Altice F.L., Hickman M., Vikerman P. (2018). Lancet Infect. Dis., 18: 1397-1409.
  40. Wang E.A., Pletcher M., Lin F. et al. (2009). Incarceration, incident hypertension, and access to health care: findings from the Coronary Artery Risk Development in Young Adults (CARDIA) study. Arch. Intern. Med., 169(7): 687-693.
  41. Western B. (2006). Punishment and Inequality in America. New York, NY: Russell Sage.


Caricamento metriche ...